Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-03

Clinical Trial Update: Improving Glycaemic Control With L-carnitine [Phase 2]

View source ↗

Summary

This entry summarizes a Phase 2 clinical trial sponsored by the University of Nottingham evaluating L-carnitine for improving glycemic control in Type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-carnitine (L-carnitine)

Snippet

Sponsor: University of Nottingham | Conditions: Type 2 Diabetes | Phase 2 | Status: UNKNOWN